Precigen End Period Cash Flow from 2010 to 2024

PGEN Stock  USD 0.93  0.02  2.20%   
Precigen End Period Cash Flow yearly trend continues to be very stable with very little volatility. End Period Cash Flow is likely to drop to about 7.5 M. During the period from 2010 to 2024, Precigen End Period Cash Flow quarterly data regression pattern had sample variance of 1381.6 T and median of  48,596,000. View All Fundamentals
 
End Period Cash Flow  
First Reported
2012-03-31
Previous Quarter
9.6 M
Current Value
24.7 M
Quarterly Volatility
38.5 M
 
Yuan Drop
 
Covid
Check Precigen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Precigen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.3 M, Interest Expense of 444.6 K or Total Revenue of 5.9 M, as well as many indicators such as Price To Sales Ratio of 55.27, Dividend Yield of 0.0 or PTB Ratio of 4.45. Precigen financial statements analysis is a perfect complement when working with Precigen Valuation or Volatility modules.
  
Check out the analysis of Precigen Correlation against competitors.
To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.

Latest Precigen's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Precigen over the last few years. It is Precigen's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Precigen's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Very volatile
   End Period Cash Flow   
       Timeline  

Precigen End Period Cash Flow Regression Statistics

Arithmetic Mean48,749,507
Geometric Mean35,130,703
Coefficient Of Variation76.25
Mean Deviation27,417,127
Median48,596,000
Standard Deviation37,170,220
Sample Variance1381.6T
Range128.3M
R-Value(0)
Mean Square Error1487.9T
R-Squared0.00000102
Significance1.00
Slope(8,410)
Total Sum of Squares19342.8T

Precigen End Period Cash Flow History

20247.5 M
20237.8 M
202248.6 M
202143.3 M
202052.2 M
201968.4 M
2018110.2 M

About Precigen Financial Statements

Precigen investors utilize fundamental indicators, such as End Period Cash Flow, to predict how Precigen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash Flow7.8 M7.5 M

Pair Trading with Precigen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precigen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Precigen Stock

  0.63ELAN Elanco Animal HealthPairCorr

Moving against Precigen Stock

  0.62EWTX Edgewise TherapeuticsPairCorr
  0.6BHC Bausch Health CompaniesPairCorr
  0.54BMY Bristol Myers Squibb Sell-off TrendPairCorr
  0.53GANX Gain TherapeuticsPairCorr
  0.47GILD Gilead SciencesPairCorr
The ability to find closely correlated positions to Precigen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precigen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precigen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precigen to buy it.
The correlation of Precigen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precigen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precigen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Precigen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:
Check out the analysis of Precigen Correlation against competitors.
To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.54)
Revenue Per Share
0.018
Quarterly Revenue Growth
(0.59)
Return On Assets
(0.42)
Return On Equity
(1.29)
The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.